Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for early biomarker-positive acute kidney injury in ICU patients
ACTRN12606000058572Phase 4Completed
- Sponsor
- Health Research Council of New Zealand
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute kidney failure (AKF) comparing Erythropoietin with Placebo (2 arms). Primary endpoint: Achieved plasma creatinine levels. Started Jan 2006; status: completed.
02
Drugs
erythropoietin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ACTRN12606000058572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000058572.